BONMAX PTH 750MCG

Bonmax PTH Cartridge contains Teriparatide, a lab-synthesized form of the naturally occurring parathyroid hormone (PTH). It is prescribed for the treatment of osteoporosis—a condition where bones become brittle and fragile due to decreased bone density—particularly in individuals at high risk of fractures. This medication plays a crucial role in improving bone strength by stimulating the activity of osteoblasts, the bone-forming cells, which leads to increased bone mineral density and promotes the formation of new bone tissue.

Bonmax PTH not only enhances bone regeneration but also supports the early stages of fracture healing by encouraging the development of the callus, which is the structural foundation for bone repair. As a result, patients using this therapy often experience improved recovery outcomes and a reduced risk of future fractures.

However, it is contraindicated in individuals with known allergies to Teriparatide or any of the ingredients in the cartridge. Its use is also strictly avoided in patients with a history of bone cancers like osteosarcoma, bone metastases, or those who have previously undergone radiation therapy to the skeletal system, due to an elevated risk of serious complications including malignancy recurrence.

As with any osteoporosis therapy, Bonmax PTH Cartridge should be used under the close supervision of a healthcare professional, who will assess the risks and benefits based on the individual’s medical history and current condition.